Diamyd Medical has received a Notice of Grant in Japan for a patent covering the use of insulin-based antigens to treat individuals with type 1 diabetes who carry the HLA DR4-DQ8 genetic marker. Once ...
With Human Rights Day upon us, South Africa reflects on the promise of life for every citizen. The pressing need for registered stem cell donors reminds us that lives hinge on collective action — ...
Morning Overview on MSN
New prostate cancer immunotherapy cuts biomarkers by up to 99% in trial
A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...
Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological ...
Wellbeing Magazine on MSN
Is arthritis hereditary? All you need to know
Some types of arthritis, like rheumatoid, juvenile, and psoriatic arthritis, have hereditary links. Learn which forms run in ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory illness with systemic immune cell activation, inflammation, widespread multiorgan dysfunction, and thrombosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results